Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Herpes simplex virus 1 ICP0 co-localizes with a SUMO-specific protease.

Bailey D, O'Hare P.

J Gen Virol. 2002 Dec;83(Pt 12):2951-64.

PMID:
12466471
2.
3.

A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defence.

Boutell C, Cuchet-Lourenço D, Vanni E, Orr A, Glass M, McFarlane S, Everett RD.

PLoS Pathog. 2011 Sep;7(9):e1002245. doi: 10.1371/journal.ppat.1002245. Epub 2011 Sep 15.

4.

Herpes simplex virus 1 ubiquitin ligase ICP0 interacts with PML isoform I and induces its SUMO-independent degradation.

Cuchet-Lourenço D, Vanni E, Glass M, Orr A, Everett RD.

J Virol. 2012 Oct;86(20):11209-22. Epub 2012 Aug 8.

5.

Sequences related to SUMO interaction motifs in herpes simplex virus 1 protein ICP0 act cooperatively to stimulate virus infection.

Everett RD, Boutell C, Pheasant K, Cuchet-Lourenço D, Orr A.

J Virol. 2014 Mar;88(5):2763-74. doi: 10.1128/JVI.03417-13. Epub 2013 Dec 18.

7.

Identification of a novel higher molecular weight isoform of USP7/HAUSP that interacts with the Herpes simplex virus type-1 immediate early protein ICP0.

Antrobus R, Boutell C.

Virus Res. 2008 Oct;137(1):64-71. doi: 10.1016/j.virusres.2008.05.017. Epub 2008 Jul 17.

PMID:
18590780
8.

A RING finger ubiquitin ligase is protected from autocatalyzed ubiquitination and degradation by binding to ubiquitin-specific protease USP7.

Canning M, Boutell C, Parkinson J, Everett RD.

J Biol Chem. 2004 Sep 10;279(37):38160-8. Epub 2004 Jul 6.

9.
10.

Novel Role for Protein Inhibitor of Activated STAT 4 (PIAS4) in the Restriction of Herpes Simplex Virus 1 by the Cellular Intrinsic Antiviral Immune Response.

Conn KL, Wasson P, McFarlane S, Tong L, Brown JR, Grant KG, Domingues P, Boutell C.

J Virol. 2016 Apr 14;90(9):4807-4826. doi: 10.1128/JVI.03055-15. Print 2016 May.

12.

Ubiquitin-specific protease 9X in host cells interacts with herpes simplex virus 1 ICP0.

Sato Y, Kato A, Arii J, Koyanagi N, Kozuka-Hata H, Oyama M, Kawaguchi Y.

J Vet Med Sci. 2016 Mar;78(3):405-10. doi: 10.1292/jvms.15-0598. Epub 2015 Nov 21.

13.
16.

ICP0 enables and monitors the function of D cyclins in herpes simplex virus 1 infected cells.

Kalamvoki M, Roizman B.

Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14576-80. doi: 10.1073/pnas.0906905106. Epub 2009 Aug 12.

17.

Functional characterization of residues required for the herpes simplex virus 1 E3 ubiquitin ligase ICP0 to interact with the cellular E2 ubiquitin-conjugating enzyme UBE2D1 (UbcH5a).

Vanni E, Gatherer D, Tong L, Everett RD, Boutell C.

J Virol. 2012 Jun;86(11):6323-33. doi: 10.1128/JVI.07210-11. Epub 2012 Mar 21.

18.

The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms.

Everett RD, Freemont P, Saitoh H, Dasso M, Orr A, Kathoria M, Parkinson J.

J Virol. 1998 Aug;72(8):6581-91.

19.

Herpes simplex virus type 1 ICP0 phosphorylation mutants impair the E3 ubiquitin ligase activity of ICP0 in a cell type-dependent manner.

Boutell C, Everett R, Hilliard J, Schaffer P, Orr A, Davido D.

J Virol. 2008 Nov;82(21):10647-56. doi: 10.1128/JVI.01063-08. Epub 2008 Aug 20.

Supplemental Content

Support Center